Gujarat-based Shukra Pharmaceuticals has secured a contract from HSCC (India) Ltd., a Government of India enterprise under the Ministry of Housing and Urban Affairs, acting on behalf of the Ministry of External Affairs (MEA).

In a stock exchange filing, the company announced that it received a Letter of Award (LoA) on August 28, 2025, for the supply of medicines and diagnostic kits to Afghanistan (Technical Mission of India, Kabul).

The contract, valued at INR 24.06 crore, covers the supply of essential medicines and diagnostic kits, including packing, forwarding, insurance, and delivery to the consignee site in Afghanistan.

Shukra Pharmaceuticals said the order further strengthens its international presence and reaffirms the company’s capabilities to execute large-scale global healthcare supply projects, especially under government-backed initiatives.

The company believes that this achievement will have a positive impact on its business growth, brand positioning, and stakeholders’ value creation. 

Shukra Pharmaceuticals is a fast-growing global pharmaceutical company with a strong presence across the CIS, Africa, and Southeast Asia.

The company boasts mega manufacturing capabilities, producing up to 720 million tablets and 90 million capsules annually in oral solids, along with an impressive injectables capacity of 40 million ampoules and 50 million vials each year.